{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "22", "@timestamp": "2024-02-22T00:43:26.000026-05:00", "@year": "2024", "@month": "02"}, "ait:date-sort": {"@day": "01", "@year": "2016", "@month": "06"}}, "xocs:meta": {"xocs:funding-list": {"@pui-match": "primary", "@has-funding-info": "1", "xocs:funding": [{"xocs:funding-agency-matched-string": "Innova Diagnostics"}, {"xocs:funding-agency-matched-string": "NIH", "xocs:funding-agency-acronym": "NIH", "xocs:funding-agency": "National Institutes of Health", "xocs:funding-id": "UL1-TR000135", "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100000002", "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"}, {"xocs:funding-agency-acronym": "NCI", "xocs:funding-agency": "National Cancer Institute", "xocs:funding-id": "P50CA102701", "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100000054", "xocs:funding-agency-country": "http://sws.geonames.org/6252001"}, {"xocs:funding-agency-matched-string": "Mayo Clinic", "xocs:funding-agency": "Mayo Clinic", "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100000871", "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"}, {"xocs:funding-agency-matched-string": "Bayer AG", "xocs:funding-agency": "Bayer", "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004326", "xocs:funding-agency-country": "http://sws.geonames.org/2921044/"}, {"xocs:funding-agency-matched-string": "Gilead Sciences", "xocs:funding-agency": "Gilead Sciences", "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100005564", "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"}, {"xocs:funding-agency-matched-string": "Ariad Pharmaceuticals", "xocs:funding-agency": "Ariad Pharmaceuticals", "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100006413", "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"}, {"xocs:funding-agency-matched-string": "BTG", "xocs:funding-agency": "BTG", "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100014869", "xocs:funding-agency-country": "http://sws.geonames.org/2635167/"}], "xocs:funding-addon-generated-timestamp": "2024-01-27T07:44:58.843Z", "xocs:funding-text": "Supported by Mayo Clinic SPORE in pancreatic cancer (National Institutes of Health [NIH] Grant No. P50CA102701) and the Mayo Clinic Center for Translational Science Activities (NIH National Center for Research Resources Clinical and Translational Science Award Grant No. UL1-TR000135). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Bristol-Myers Squibb (Inst), Gilead Sciences (Inst), Wako Diagnostics (Inst), Innova Diagnostics (Inst), Bayer AG (Inst), BTG (Inst), Ariad Pharmaceuticals (Inst)", "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"}}, "bibrecord": {"head": {"author-group": [{"affiliation": {"country": "United States", "@afid": "60010480", "@country": "usa", "organization": [{"$": "Mayo Clinic College of Medicine"}, {"$": "Mayo Clinic Cancer Center"}], "affiliation-id": [{"@afid": "60010480"}, {"@afid": "60081114"}]}, "author": [{"ce:given-name": "Roongruedee", "preferred-name": {"ce:given-name": "Roongruedee", "ce:initials": "R.", "ce:surname": "Chaiteerakij", "ce:indexed-name": "Chaiteerakij R."}, "@seq": "1", "ce:initials": "R.", "@_fa": "true", "@type": "auth", "ce:surname": "Chaiteerakij", "@auid": "24764920200", "ce:indexed-name": "Chaiteerakij R."}, {"ce:given-name": "Lewis R.", "preferred-name": {"ce:given-name": "Lewis R.", "ce:initials": "L.R.", "ce:surname": "Roberts", "ce:indexed-name": "Roberts L.R."}, "@seq": "8", "ce:initials": "L.R.", "@date-locked": "2022-09-24T07:28:32.626", "@_fa": "true", "@type": "auth", "ce:surname": "Roberts", "@auid": "57816837300", "ce:indexed-name": "Roberts L.R."}]}, {"affiliation": {"country": "United States", "address-part": "200 First St SW", "postal-code": "55905", "@afid": "60005558", "@country": "usa", "city": "Rochester", "organization": [{"$": "Division of Biomedical Statistics and Informatics"}, {"$": "Department of Health Sciences Research"}, {"$": "Mayo Clinic"}], "affiliation-id": {"@afid": "60005558", "@dptid": "103323932"}, "state": "MN", "@dptid": "103323932"}, "author": [{"ce:given-name": "Gloria M.", "preferred-name": {"ce:given-name": "Gloria M.", "ce:initials": "G.M.", "ce:surname": "Petersen", "ce:indexed-name": "Petersen G.M."}, "@seq": "2", "ce:initials": "G.M.", "@date-locked": "2018-06-12T00:57:22.397", "@_fa": "true", "@type": "auth", "ce:surname": "Petersen", "@auid": "7202062781", "ce:indexed-name": "Petersen G.M."}, {"ce:given-name": "William R.", "preferred-name": {"ce:given-name": "William R.", "ce:initials": "W.R.", "ce:surname": "Bamlet", "ce:indexed-name": "Bamlet W.R."}, "@seq": "3", "ce:initials": "W.R.", "@date-locked": "2017-07-28T07:18:49.573", "@_fa": "true", "@type": "auth", "ce:surname": "Bamlet", "@auid": "6507377111", "ce:indexed-name": "Bamlet W.R."}, {"ce:given-name": "Kari G.", "preferred-name": {"ce:given-name": "Kari G.", "ce:initials": "K.G.", "ce:surname": "Chaffee", "ce:indexed-name": "Chaffee K.G."}, "@seq": "4", "ce:initials": "K.G.", "@date-locked": "2021-02-04T05:43:52.121", "@_fa": "true", "@type": "auth", "ce:surname": "Chaffee", "@auid": "7102576604", "ce:indexed-name": "Chaffee K.G."}, {"ce:given-name": "David B.", "preferred-name": {"ce:given-name": "David B.", "ce:initials": "D.B.", "ce:surname": "Zhen", "ce:indexed-name": "Zhen D.B."}, "@seq": "5", "ce:initials": "D.B.", "@_fa": "true", "@type": "auth", "ce:surname": "Zhen", "@auid": "56880000500", "ce:indexed-name": "Zhen D.B."}, {"ce:given-name": "Patrick A.", "preferred-name": {"ce:given-name": "Patrick A.", "ce:initials": "P.A.", "ce:surname": "Burch", "ce:indexed-name": "Burch P.A."}, "@seq": "6", "ce:initials": "P.A.", "@_fa": "true", "@type": "auth", "ce:surname": "Burch", "@auid": "7102736707", "ce:indexed-name": "Burch P.A."}, {"ce:given-name": "Emma R.", "preferred-name": {"ce:given-name": "Emma R.", "ce:initials": "E.R.", "ce:surname": "Leof", "ce:indexed-name": "Leof E.R."}, "@seq": "7", "ce:initials": "E.R.", "@_fa": "true", "@type": "auth", "ce:surname": "Leof", "@auid": "56789771700", "ce:indexed-name": "Leof E.R."}, {"ce:given-name": "Ann L.", "preferred-name": {"ce:given-name": "Ann L.", "ce:initials": "A.L.", "ce:surname": "Oberg", "ce:indexed-name": "Oberg A.L."}, "@seq": "9", "ce:initials": "A.L.", "@_fa": "true", "@type": "auth", "ce:degrees": "PhD", "ce:surname": "Oberg", "@auid": "7006697550", "ce:indexed-name": "Oberg A.L."}]}, {"affiliation": {"country": "Thailand", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Chulalongkorn University"}, {"$": "King Chulalongkorn Memorial Hospital"}, {"$": "Thai Red Cross Society"}], "affiliation-id": [{"@afid": "60028190"}, {"@afid": "60031780"}, {"@afid": "60022183"}]}, "author": [{"ce:given-name": "Roongruedee", "preferred-name": {"ce:given-name": "Roongruedee", "ce:initials": "R.", "ce:surname": "Chaiteerakij", "ce:indexed-name": "Chaiteerakij R."}, "@seq": "1", "ce:initials": "R.", "@_fa": "true", "@type": "auth", "ce:surname": "Chaiteerakij", "@auid": "24764920200", "ce:indexed-name": "Chaiteerakij R."}]}, {"affiliation": {"country": "United States", "@afid": "60025778", "@country": "usa", "city": "Ann Arbor", "organization": {"$": "University of Michigan"}, "affiliation-id": {"@afid": "60025778"}, "state": "MI"}, "author": [{"ce:given-name": "David B.", "preferred-name": {"ce:given-name": "David B.", "ce:initials": "D.B.", "ce:surname": "Zhen", "ce:indexed-name": "Zhen D.B."}, "@seq": "5", "ce:initials": "D.B.", "@_fa": "true", "@type": "auth", "ce:surname": "Zhen", "@auid": "56880000500", "ce:indexed-name": "Zhen D.B."}]}], "citation-title": "Metformin use and survival of patients with pancreatic cancer: A cautionary lesson", "abstracts": "\u00a9 2016 by American Society of Clinical Oncology.Purpose: The inclusion of metformin in the treatment arms of cancer clinical trials is based on improved survival that has been demonstrated in retrospective epidemiologic studies; however, unintended biases may exist when analysis is performed by using a conventional Cox proportional hazards regression model with dichotomous ever/never categorization. We examined the impact of metformin exposure definitions, analytical methods, and patient selection on the estimated effect size of metformin exposure on survival in a large cohort of patients with pancreatic ductal adenocarcinoma (PDAC). Patients and Methods: Of newly diagnosed patients with PDAC with diabetes, 980 were retrospectively included, and exposure to metformin documented. Median survival was assessed by using Kaplan-Meier and log-rank methods. Hazard ratios (HR) and 95% CIs were computed to compare time-varying covariate analysis with conventional Cox proportional hazards regression analysis. Results: Median survival of metformin users versus nonusers was 9.9 versus 8.9 months, respectively. By the time-varying covariate analysis, metformin use was not statistically significantly associated with improved survival (HR, 0.93; 95% CI, 0.81 to1.07; P = .28). There was no evidence of benefit in the subset of patients who were na\u00efve to metformin at the time of PDAC diagnosis (most representative of patients enrolled in clinical trials; HR, 1.01; 95% CI, 0.80 to 1.30; P = .89); however, when the analysis was performed by using the conventional Cox model, an artificial survival benefit of metformin was detected (HR, 0.88; 95% CI, 0.77 to 1.01; P = .08), which suggested biased results from the conventional Cox analysis. Conclusion: Our findings did not suggest the benefit of metformin use after patients are diagnosed with PDAC. We highlight the importance of patient selection and appropriate statistical analytical methods when studying medication exposure and cancer survival.", "correspondence": {"affiliation": {"country": "United States", "address-part": "200 First St SW", "postal-code": "55905", "@country": "usa", "city": "Rochester", "organization": [{"$": "Division of Biomedical Statistics and Informatics"}, {"$": "Department of Health Sciences Research"}, {"$": "Mayo Clinic"}], "state": "MN"}, "person": {"ce:given-name": "Ann L.", "ce:initials": "A.L.", "ce:degrees": "PhD", "ce:surname": "Oberg", "ce:indexed-name": "Oberg A.L."}}, "citation-info": {"citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"website": {"ce:e-address": {"$": "http://jco.ascopubs.org/content/34/16/1898.full.pdf+html", "@type": "email"}}, "translated-sourcetitle": {"$": "Journal of Clinical Oncology", "@xml:lang": "eng"}, "volisspag": {"voliss": {"@volume": "34", "@issue": "16"}, "pagerange": {"@first": "1898", "@last": "1904"}}, "@type": "j", "sourcetitle": "Journal of Clinical Oncology", "publicationdate": {"month": "06", "year": "2016", "date-text": {"@xfab-added": "true", "$": "1 June 2016"}, "day": "01"}, "codencode": "JCOND", "sourcetitle-abbrev": "J. Clin. Oncol.", "@country": "usa", "issn": [{"$": "15277755", "@type": "electronic"}, {"$": "0732183X", "@type": "print"}], "publicationyear": {"@first": "2016"}, "publisher": {"publishername": "American Society of Clinical Oncology", "ce:e-address": {"$": "jcoservice@asco.org", "@type": "email"}}, "@srcid": "29949"}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "CABSCLASS", "classification": [{"classification-code": "87.4.1", "classification-description": "CANCER RESEARCH; TREATMENT; Chemotherapy"}, {"classification-code": "87.5.6", "classification-description": "CANCER RESEARCH; CLINICAL INVESTIGATIONS BY ORGAN SITE; Other Digestive System"}]}, {"@type": "EMCLASS", "classification": [{"classification-code": "16", "classification-description": "Cancer"}, {"classification-code": "37", "classification-description": "Drug Literature Index"}, {"classification-code": "48", "classification-description": "Gastroenterology"}]}, {"@type": "ASJC", "classification": [{"$": "2730"}, {"$": "1306"}]}, {"@type": "SUBJABBR", "classification": [{"$": "MEDI"}, {"$": "BIOC"}]}]}, "chemicalgroup": {"chemicals": [{"@source": "esbd", "chemical": {"cas-registry-number": [{"$": "1115-70-4"}, {"$": "657-24-9"}], "chemical-name": "metformin"}}, {"@source": "nlm", "chemical": {"chemical-name": "Metformin"}}]}}, "grantlist": {"@complete": "y", "grant-text": {"$": "Supported by Mayo Clinic SPORE in pancreatic cancer (National Institutes of Health [NIH] Grant No. P50CA102701) and the Mayo Clinic Center for Translational Science Activities (NIH National Center for Research Resources Clinical and Translational Science Award Grant No. UL1-TR000135). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Bristol-Myers Squibb (Inst), Gilead Sciences (Inst), Wako Diagnostics (Inst), Innova Diagnostics (Inst), Bayer AG (Inst), BTG (Inst), Ariad Pharmaceuticals (Inst)", "@xml:lang": "eng"}, "grant": [{"grant-agency": "Ariad Pharmaceuticals"}, {"grant-acronym": "BMS", "grant-agency": "Bristol-Myers Squibb"}, {"grant-agency": "Gilead Sciences"}, {"grant-agency": "Mayo Clinic"}, {"grant-id": "P50CA102701", "grant-acronym": "NIH", "grant-agency": "National Institutes of Health"}, {"grant-id": "UL1-TR000135", "grant-acronym": "NIH", "grant-agency": "National Institutes of Health"}]}}, "item-info": {"copyright": {"$": "Copyright 2018 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "external-source": "MEDLINE", "dbcollection": [{"$": "CABS"}, {"$": "EMBASE"}, {"$": "MEDL"}, {"$": "MOSYEA"}, {"$": "NURSNG"}, {"$": "REAXYSCAR"}, {"$": "RMC"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}], "history": {"date-created": {"@day": "06", "@timestamp": "BST 16:19:06", "@year": "2018", "@month": "07"}}, "itemidlist": {"itemid": [{"$": "610604778", "@idtype": "PUI"}, {"$": "2016204616", "@idtype": "CABS"}, {"$": "651114893", "@idtype": "CAR-ID"}, {"$": "20160426215", "@idtype": "EMBASE"}, {"$": "27069086", "@idtype": "MEDL"}, {"$": "2016077010", "@idtype": "MOSYEA"}, {"$": "2016200717", "@idtype": "NURSNG"}, {"$": "20161317148", "@idtype": "REAXYSCAR"}, {"$": "2016169747", "@idtype": "RMC"}, {"$": "20182027145", "@idtype": "SCOPUS"}, {"$": "84973162069", "@idtype": "SCP"}, {"$": "84973162069", "@idtype": "SGR"}, {"$": "617669274", "@idtype": "PUIsecondary"}], "ce:doi": "10.1200/JCO.2015.63.3511"}}, "tail": {"bibliography": {"@refcount": "20", "reference": [{"ref-fulltext": "American Cancer Society: Cancer Facts & Figures 2016. Atlanta, GA, American Cancer Society, 2016", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "refd-itemidlist": {"itemid": {"$": "84969139874", "@idtype": "SGR"}}, "ref-text": "Atlanta, GA, American Cancer Society", "ref-authors": {"author": [{"@seq": "1", "@_fa": "true", "ce:surname": "American Cancer Society", "ce:indexed-name": "American Cancer Society"}]}, "ref-sourcetitle": "Cancer Facts & Figures 2016"}}, {"ref-fulltext": "Smith BD, Smith GL, Hurria A, et al: Future of cancer incidence in the United States: Burdens upon an aging, changing nation. J Clin Oncol 27:2758-2765, 2009", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Future of cancer incidence in the United States: Burdens upon an aging, changing nation"}, "refd-itemidlist": {"itemid": {"$": "67649993396", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "27"}, "pagerange": {"@first": "2758", "@last": "2765"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.D.", "@_fa": "true", "ce:surname": "Smith", "ce:indexed-name": "Smith B.D."}, {"@seq": "2", "ce:initials": "G.L.", "@_fa": "true", "ce:surname": "Smith", "ce:indexed-name": "Smith G.L."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Hurria", "ce:indexed-name": "Hurria A."}], "et-al": null}, "ref-sourcetitle": "J Clin Oncol"}}, {"ref-fulltext": "Gandini S, Puntoni M, Heckman-Stoddard BM, et al: Metformin and cancer risk and mortality: A systematic review and meta-analysis taking into account biases and confounders. Cancer Prev Res (Phila) 7:867-885, 2014", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Metformin and cancer risk and mortality: A systematic review and meta-analysis taking into account biases and confounders"}, "refd-itemidlist": {"itemid": {"$": "84907296915", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "7"}, "pagerange": {"@first": "867", "@last": "885"}}, "ref-text": "Phila", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Gandini", "ce:indexed-name": "Gandini S."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Puntoni", "ce:indexed-name": "Puntoni M."}, {"@seq": "3", "ce:initials": "B.M.", "@_fa": "true", "ce:surname": "Heckman-Stoddard", "ce:indexed-name": "Heckman-Stoddard B.M."}], "et-al": null}, "ref-sourcetitle": "Cancer Prev Res"}}, {"ref-fulltext": "Zhang ZJ, Li S: The prognostic value of metformin for cancer patients with concurrent diabetes: A systematic review and meta-analysis. Diabetes Obes Metab 16:707-710, 2014", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "The prognostic value of metformin for cancer patients with concurrent diabetes: A systematic review and meta-analysis"}, "refd-itemidlist": {"itemid": {"$": "84904398047", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "16"}, "pagerange": {"@first": "707", "@last": "710"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "Z.J.", "@_fa": "true", "ce:surname": "Zhang", "ce:indexed-name": "Zhang Z.J."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Li", "ce:indexed-name": "Li S."}]}, "ref-sourcetitle": "Diabetes Obes Metab"}}, {"ref-fulltext": "Sadeghi N, Abbruzzese JL, Yeung SC, et al: Metformin use is associated with better survival of diabetic patients with pancreatic cancer. Clin Cancer Res 18:2905-2912, 2012", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Metformin use is associated with better survival of diabetic patients with pancreatic cancer"}, "refd-itemidlist": {"itemid": {"$": "84861127026", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "18"}, "pagerange": {"@first": "2905", "@last": "2912"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Sadeghi", "ce:indexed-name": "Sadeghi N."}, {"@seq": "2", "ce:initials": "J.L.", "@_fa": "true", "ce:surname": "Abbruzzese", "ce:indexed-name": "Abbruzzese J.L."}, {"@seq": "3", "ce:initials": "S.C.", "@_fa": "true", "ce:surname": "Yeung", "ce:indexed-name": "Yeung S.C."}], "et-al": null}, "ref-sourcetitle": "Clin Cancer Res"}}, {"ref-fulltext": "Reference deleted", "@id": "6", "ref-info": {"refd-itemidlist": {"itemid": {"$": "84973166809", "@idtype": "SGR"}}, "ref-text": "Reference deleted"}}, {"ref-fulltext": "Pollak M: Overcoming drug development bottlenecks with repurposing: Repurposing biguanides to target energy metabolism for cancer treatment. Nat Med 20:591-593, 2014", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Overcoming drug development bottlenecks with repurposing: Repurposing biguanides to target energy metabolism for cancer treatment"}, "refd-itemidlist": {"itemid": {"$": "84902110574", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "20"}, "pagerange": {"@first": "591", "@last": "593"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Pollak", "ce:indexed-name": "Pollak M."}]}, "ref-sourcetitle": "Nat Med"}}, {"ref-fulltext": "National Institutes of Health: ClinicalTrials.gov. https://clinicaltrials.gov/", "@id": "8", "ref-info": {"ref-website": {"ce:e-address": {"$": "https://clinicaltrials.gov/", "@type": "email"}}, "refd-itemidlist": {"itemid": {"$": "84973166792", "@idtype": "SGR"}}, "ref-text": "ClinicalTrials.gov", "ref-authors": {"author": [{"@seq": "1", "@_fa": "true", "ce:surname": "National Institutes of Health", "ce:indexed-name": "National Institutes of Health"}]}}}, {"ref-fulltext": "Suissa S, Azoulay L: Metformin and the risk of cancer: Time-related biases in observational studies. Diabetes Care 35:2665-2673, 2012", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Metformin and the risk of cancer: Time-related biases in observational studies"}, "refd-itemidlist": {"itemid": {"$": "84869788946", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "35"}, "pagerange": {"@first": "2665", "@last": "2673"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Suissa", "ce:indexed-name": "Suissa S."}, {"@seq": "2", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Azoulay", "ce:indexed-name": "Azoulay L."}]}, "ref-sourcetitle": "Diabetes Care"}}, {"ref-fulltext": "Zhou Z, Rahme E, Abrahamowicz M, et al: Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: A comparison of methods. Am J Epidemiol 162:1016-1023, 2005", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: A comparison of methods"}, "refd-itemidlist": {"itemid": {"$": "27744473507", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "162"}, "pagerange": {"@first": "1016", "@last": "1023"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "Z.", "@_fa": "true", "ce:surname": "Zhou", "ce:indexed-name": "Zhou Z."}, {"@seq": "2", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Rahme", "ce:indexed-name": "Rahme E."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Abrahamowicz", "ce:indexed-name": "Abrahamowicz M."}], "et-al": null}, "ref-sourcetitle": "Am J Epidemiol"}}, {"ref-fulltext": "Suissa S: Immortal time bias in pharmacoepidemiology. Am J Epidemiol 167:492-499, 2008", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Immortal time bias in pharmacoepidemiology"}, "refd-itemidlist": {"itemid": {"$": "39349101029", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "167"}, "pagerange": {"@first": "492", "@last": "499"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Suissa", "ce:indexed-name": "Suissa S."}]}, "ref-sourcetitle": "Am J Epidemiol"}}, {"ref-fulltext": "Suissa S: Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf 16:241-249, 2007", "@id": "12", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Immortal time bias in observational studies of drug effects"}, "refd-itemidlist": {"itemid": {"$": "33947227921", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "16"}, "pagerange": {"@first": "241", "@last": "249"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Suissa", "ce:indexed-name": "Suissa S."}]}, "ref-sourcetitle": "Pharmacoepidemiol Drug Saf"}}, {"ref-fulltext": "Petersen GM, de Andrade M, Goggins M, et al: Pancreatic cancer genetic epidemiology consortium. Cancer Epidemiol Biomarkers Prev 15:704-710, 2006", "@id": "13", "ref-info": {"ref-publicationyear": {"@first": "2006"}, "ref-title": {"ref-titletext": "Pancreatic cancer genetic epidemiology consortium"}, "refd-itemidlist": {"itemid": {"$": "33646231772", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "15"}, "pagerange": {"@first": "704", "@last": "710"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.M.", "@_fa": "true", "ce:surname": "Petersen", "ce:indexed-name": "Petersen G.M."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "De Andrade", "ce:indexed-name": "De Andrade M."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Goggins", "ce:indexed-name": "Goggins M."}], "et-al": null}, "ref-sourcetitle": "Cancer Epidemiol Biomarkers Prev"}}, {"ref-fulltext": "American Diabetes Association: Standards of medical care in diabetes-2011. Diabetes Care 34:S11-S61, 2011 (suppl 1)", "@id": "14", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Standards of medical care in diabetes-2011"}, "refd-itemidlist": {"itemid": {"$": "78651338445", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "34"}, "pagerange": {"@first": "S11", "@last": "S61"}}, "ref-authors": {"author": [{"@seq": "1", "@_fa": "true", "ce:surname": "American Diabetes Association", "ce:indexed-name": "American Diabetes Association"}]}, "ref-sourcetitle": "Diabetes Care"}}, {"ref-fulltext": "Fisher LD, Lin DY: Time-dependent covariates in the Cox proportional-hazards regression model. Annu Rev Public Health 20:145-157, 1999", "@id": "15", "ref-info": {"ref-publicationyear": {"@first": "1999"}, "ref-title": {"ref-titletext": "Time-dependent covariates in the Cox proportional-hazards regression model"}, "refd-itemidlist": {"itemid": {"$": "0033046689", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "20"}, "pagerange": {"@first": "145", "@last": "157"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "L.D.", "@_fa": "true", "ce:surname": "Fisher", "ce:indexed-name": "Fisher L.D."}, {"@seq": "2", "ce:initials": "D.Y.", "@_fa": "true", "ce:surname": "Lin", "ce:indexed-name": "Lin D.Y."}]}, "ref-sourcetitle": "Annu Rev Public Health"}}, {"ref-fulltext": "Morales DR, Morris AD: Metformin in cancer treatment and prevention. Annu Rev Med 66:17-29, 2015", "@id": "16", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Metformin in cancer treatment and prevention"}, "refd-itemidlist": {"itemid": {"$": "84921405225", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "66"}, "pagerange": {"@first": "17", "@last": "29"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.R.", "@_fa": "true", "ce:surname": "Morales", "ce:indexed-name": "Morales D.R."}, {"@seq": "2", "ce:initials": "A.D.", "@_fa": "true", "ce:surname": "Morris", "ce:indexed-name": "Morris A.D."}]}, "ref-sourcetitle": "Annu Rev Med"}}, {"ref-fulltext": "van Walraven C, Davis D, Forster AJ, et al: Time-dependent bias was common in survival analyses published in leading clinical journals. J Clin Epidemiol 57:672-682, 2004", "@id": "17", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Time-dependent bias was common in survival analyses published in leading clinical journals"}, "refd-itemidlist": {"itemid": {"$": "4444283796", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "57"}, "pagerange": {"@first": "672", "@last": "682"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Van Walraven", "ce:indexed-name": "Van Walraven C."}, {"@seq": "2", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Davis", "ce:indexed-name": "Davis D."}, {"@seq": "3", "ce:initials": "A.J.", "@_fa": "true", "ce:surname": "Forster", "ce:indexed-name": "Forster A.J."}], "et-al": null}, "ref-sourcetitle": "J Clin Epidemiol"}}, {"ref-fulltext": "Shariff SZ, Cuerden MS, Jain AK, et al: The secret of immortal time bias in epidemiologic studies. J Am Soc Nephrol 19:841-843, 2008", "@id": "18", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "The secret of immortal time bias in epidemiologic studies"}, "refd-itemidlist": {"itemid": {"$": "44049108508", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "19"}, "pagerange": {"@first": "841", "@last": "843"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.Z.", "@_fa": "true", "ce:surname": "Shariff", "ce:indexed-name": "Shariff S.Z."}, {"@seq": "2", "ce:initials": "M.S.", "@_fa": "true", "ce:surname": "Cuerden", "ce:indexed-name": "Cuerden M.S."}, {"@seq": "3", "ce:initials": "A.K.", "@_fa": "true", "ce:surname": "Jain", "ce:indexed-name": "Jain A.K."}], "et-al": null}, "ref-sourcetitle": "J Am Soc Nephrol"}}, {"ref-fulltext": "Allison PD: Time dependent covariates, in: Survival Analysis Using SAS: A Practical Guide. Cary, NC, SAS Institute, 2000, pp 138-153", "@id": "19", "ref-info": {"ref-publicationyear": {"@first": "2000"}, "ref-title": {"ref-titletext": "Time dependent covariates"}, "refd-itemidlist": {"itemid": {"$": "81255187075", "@idtype": "SGR"}}, "ref-volisspag": {"pagerange": {"@first": "138", "@last": "153"}}, "ref-text": "Cary, NC, SAS Institute", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.D.", "@_fa": "true", "ce:surname": "Allison", "ce:indexed-name": "Allison P.D."}]}, "ref-sourcetitle": "Survival Analysis Using SAS: A Practical Guide"}}, {"ref-fulltext": "Wilmink J, Kordes S, Zwinderman K, et al: A phase II randomized, placebo controlled study to evaluate the efficacy of the combination of gemcitabine, erlotinib, and metformin in patients with locally advanced or metastatic pancreatic cancer. J Clin Oncol 32:5s, 2014 (abstr 4021)", "@id": "20", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "A phase II randomized, placebo controlled study to evaluate the efficacy of the combination of gemcitabine, erlotinib, and metformin in patients with locally advanced or metastatic pancreatic cancer"}, "refd-itemidlist": {"itemid": {"$": "84905167677", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "32"}, "pagerange": {"@first": "5s"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Wilmink", "ce:indexed-name": "Wilmink J."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Kordes", "ce:indexed-name": "Kordes S."}, {"@seq": "3", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Zwinderman", "ce:indexed-name": "Zwinderman K."}], "et-al": null}, "ref-sourcetitle": "J Clin Oncol"}}]}}}}, "affiliation": [{"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}, {"affiliation-city": "Ann Arbor", "@id": "60025778", "affilname": "University of Michigan, Ann Arbor", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025778", "affiliation-country": "United States"}, {"affiliation-city": "Rochester", "@id": "60010480", "affilname": "Mayo Clinic Cancer Center", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010480", "affiliation-country": "United States"}, {"affiliation-city": "Rochester", "@id": "60005558", "affilname": "Mayo Clinic", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558", "affiliation-country": "United States"}], "coredata": {"srctype": "j", "eid": "2-s2.0-84973162069", "dc:description": "Purpose: The inclusion of metformin in the treatment arms of cancer clinical trials is based on improved survival that has been demonstrated in retrospective epidemiologic studies; however, unintended biases may exist when analysis is performed by using a conventional Cox proportional hazards regression model with dichotomous ever/never categorization. We examined the impact of metformin exposure definitions, analytical methods, and patient selection on the estimated effect size of metformin exposure on survival in a large cohort of patients with pancreatic ductal adenocarcinoma (PDAC). Patients and Methods: Of newly diagnosed patients with PDAC with diabetes, 980 were retrospectively included, and exposure to metformin documented. Median survival was assessed by using Kaplan-Meier and log-rank methods. Hazard ratios (HR) and 95% CIs were computed to compare time-varying covariate analysis with conventional Cox proportional hazards regression analysis. Results: Median survival of metformin users versus nonusers was 9.9 versus 8.9 months, respectively. By the time-varying covariate analysis, metformin use was not statistically significantly associated with improved survival (HR, 0.93; 95% CI, 0.81 to1.07; P = .28). There was no evidence of benefit in the subset of patients who were na\u00efve to metformin at the time of PDAC diagnosis (most representative of patients enrolled in clinical trials; HR, 1.01; 95% CI, 0.80 to 1.30; P = .89); however, when the analysis was performed by using the conventional Cox model, an artificial survival benefit of metformin was detected (HR, 0.88; 95% CI, 0.77 to 1.01; P = .08), which suggested biased results from the conventional Cox analysis. Conclusion: Our findings did not suggest the benefit of metformin use after patients are diagnosed with PDAC. We highlight the importance of patient selection and appropriate statistical analytical methods when studying medication exposure and cancer survival.", "pubmed-id": "27069086", "prism:coverDate": "2016-06-01", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/84973162069", "dc:creator": {"author": [{"ce:given-name": "Roongruedee", "preferred-name": {"ce:given-name": "Roongruedee", "ce:initials": "R.", "ce:surname": "Chaiteerakij", "ce:indexed-name": "Chaiteerakij R."}, "@seq": "1", "ce:initials": "R.", "@_fa": "true", "affiliation": [{"@id": "60010480", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010480"}, {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}], "ce:surname": "Chaiteerakij", "@auid": "24764920200", "author-url": "https://api.elsevier.com/content/author/author_id/24764920200", "ce:indexed-name": "Chaiteerakij R."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/84973162069"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84973162069&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84973162069&origin=inward"}], "source-id": "29949", "citedby-count": "65", "prism:volume": "34", "subtype": "ar", "dc:title": "Metformin use and survival of patients with pancreatic cancer: A cautionary lesson", "openaccess": "2", "prism:issn": "15277755 0732183X", "publishercopyright": "\u00a9 2016 by American Society of Clinical Oncology.", "prism:issueIdentifier": "16", "subtypeDescription": "Article", "prism:publicationName": "Journal of Clinical Oncology", "prism:pageRange": "1898-1904", "prism:endingPage": "1904", "openaccessFlag": null, "prism:doi": "10.1200/JCO.2015.63.3511", "prism:startingPage": "1898", "dc:identifier": "SCOPUS_ID:84973162069", "dc:publisher": "American Society of Clinical Oncologyjcoservice@asco.org"}, "idxterms": {"mainterm": [{"$": "Adenocarcinoma", "@weight": "b", "@candidate": "n"}, {"$": "Adult", "@weight": "b", "@candidate": "n"}, {"$": "Aged", "@weight": "b", "@candidate": "n"}, {"$": "Aged, 80 and over", "@weight": "b", "@candidate": "n"}, {"$": "Carcinoma, Pancreatic Ductal", "@weight": "b", "@candidate": "n"}, {"$": "Female", "@weight": "b", "@candidate": "n"}, {"$": "Humans", "@weight": "b", "@candidate": "n"}, {"$": "Male", "@weight": "b", "@candidate": "n"}, {"$": "Metformin", "@weight": "b", "@candidate": "n"}, {"$": "Middle Aged", "@weight": "b", "@candidate": "n"}, {"$": "Pancreatic Neoplasms", "@weight": "b", "@candidate": "n"}, {"$": "Proportional Hazards Models", "@weight": "b", "@candidate": "n"}, {"$": "Retrospective Studies", "@weight": "b", "@candidate": "n"}]}, "language": {"@xml:lang": "eng"}, "authkeywords": null, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Oncology", "@code": "2730", "@abbrev": "MEDI"}, {"@_fa": "true", "$": "Cancer Research", "@code": "1306", "@abbrev": "BIOC"}]}, "authors": {"author": [{"ce:given-name": "Roongruedee", "preferred-name": {"ce:given-name": "Roongruedee", "ce:initials": "R.", "ce:surname": "Chaiteerakij", "ce:indexed-name": "Chaiteerakij R."}, "@seq": "1", "ce:initials": "R.", "@_fa": "true", "affiliation": [{"@id": "60010480", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010480"}, {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}], "ce:surname": "Chaiteerakij", "@auid": "24764920200", "author-url": "https://api.elsevier.com/content/author/author_id/24764920200", "ce:indexed-name": "Chaiteerakij R."}, {"ce:given-name": "Gloria M.", "preferred-name": {"ce:given-name": "Gloria M.", "ce:initials": "G.M.", "ce:surname": "Petersen", "ce:indexed-name": "Petersen G.M."}, "@seq": "2", "ce:initials": "G.M.", "@_fa": "true", "affiliation": {"@id": "60005558", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"}, "ce:surname": "Petersen", "@auid": "7202062781", "author-url": "https://api.elsevier.com/content/author/author_id/7202062781", "ce:indexed-name": "Petersen G.M."}, {"ce:given-name": "William R.", "preferred-name": {"ce:given-name": "William R.", "ce:initials": "W.R.", "ce:surname": "Bamlet", "ce:indexed-name": "Bamlet W.R."}, "@seq": "3", "ce:initials": "W.R.", "@_fa": "true", "affiliation": {"@id": "60005558", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"}, "ce:surname": "Bamlet", "@auid": "6507377111", "author-url": "https://api.elsevier.com/content/author/author_id/6507377111", "ce:indexed-name": "Bamlet W.R."}, {"ce:given-name": "Kari G.", "preferred-name": {"ce:given-name": "Kari G.", "ce:initials": "K.G.", "ce:surname": "Chaffee", "ce:indexed-name": "Chaffee K.G."}, "@seq": "4", "ce:initials": "K.G.", "@_fa": "true", "affiliation": {"@id": "60005558", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"}, "ce:surname": "Chaffee", "@auid": "7102576604", "author-url": "https://api.elsevier.com/content/author/author_id/7102576604", "ce:indexed-name": "Chaffee K.G."}, {"ce:given-name": "David B.", "preferred-name": {"ce:given-name": "David B.", "ce:initials": "D.B.", "ce:surname": "Zhen", "ce:indexed-name": "Zhen D.B."}, "@seq": "5", "ce:initials": "D.B.", "@_fa": "true", "affiliation": [{"@id": "60005558", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"}, {"@id": "60025778", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025778"}], "ce:surname": "Zhen", "@auid": "56880000500", "author-url": "https://api.elsevier.com/content/author/author_id/56880000500", "ce:indexed-name": "Zhen D.B."}, {"ce:given-name": "Patrick A.", "preferred-name": {"ce:given-name": "Patrick A.", "ce:initials": "P.A.", "ce:surname": "Burch", "ce:indexed-name": "Burch P.A."}, "@seq": "6", "ce:initials": "P.A.", "@_fa": "true", "affiliation": {"@id": "60005558", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"}, "ce:surname": "Burch", "@auid": "7102736707", "author-url": "https://api.elsevier.com/content/author/author_id/7102736707", "ce:indexed-name": "Burch P.A."}, {"ce:given-name": "Emma R.", "preferred-name": {"ce:given-name": "Emma R.", "ce:initials": "E.R.", "ce:surname": "Leof", "ce:indexed-name": "Leof E.R."}, "@seq": "7", "ce:initials": "E.R.", "@_fa": "true", "affiliation": {"@id": "60005558", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"}, "ce:surname": "Leof", "@auid": "56789771700", "author-url": "https://api.elsevier.com/content/author/author_id/56789771700", "ce:indexed-name": "Leof E.R."}, {"ce:given-name": "Lewis R.", "preferred-name": {"ce:given-name": "Lewis R.", "ce:initials": "L.R.", "ce:surname": "Roberts", "ce:indexed-name": "Roberts L.R."}, "@seq": "8", "ce:initials": "L.R.", "@_fa": "true", "affiliation": {"@id": "60010480", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010480"}, "ce:surname": "Roberts", "@auid": "57816837300", "author-url": "https://api.elsevier.com/content/author/author_id/57816837300", "ce:indexed-name": "Roberts L.R."}, {"ce:given-name": "Ann L.", "preferred-name": {"ce:given-name": "Ann L.", "ce:initials": "A.L.", "ce:surname": "Oberg", "ce:indexed-name": "Oberg A.L."}, "@seq": "9", "ce:initials": "A.L.", "@_fa": "true", "affiliation": {"@id": "60005558", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"}, "ce:degrees": "PhD", "ce:surname": "Oberg", "@auid": "7006697550", "author-url": "https://api.elsevier.com/content/author/author_id/7006697550", "ce:indexed-name": "Oberg A.L."}]}}}